{"id":"https://openalex.org/W3012318845","doi":"https://doi.org/10.1109/ice/itmc39735.2016.9026137","title":"R&D Investment of Biotech Start-up at \u2018Death Valley\u2019","display_name":"R&D Investment of Biotech Start-up at \u2018Death Valley\u2019","publication_year":2016,"publication_date":"2016-06-01","ids":{"openalex":"https://openalex.org/W3012318845","doi":"https://doi.org/10.1109/ice/itmc39735.2016.9026137","mag":"3012318845"},"language":"en","primary_location":{"id":"doi:10.1109/ice/itmc39735.2016.9026137","is_oa":false,"landing_page_url":"https://doi.org/10.1109/ice/itmc39735.2016.9026137","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2016 International Conference on Engineering, Technology and Innovation/IEEE lnternational Technology Management Conference (ICE/ITMC)","raw_type":"proceedings-article"},"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103172463","display_name":"Takao Fujiwara","orcid":"https://orcid.org/0000-0001-8120-2082"},"institutions":[{"id":"https://openalex.org/I136259955","display_name":"Toyohashi University of Technology","ror":"https://ror.org/04ezg6d83","country_code":"JP","type":"education","lineage":["https://openalex.org/I136259955"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Takao Fujiwara","raw_affiliation_strings":["Institute of Liberal Arts and Sciences, Toyohashi University of Technology, Toyohashi, Japan"],"affiliations":[{"raw_affiliation_string":"Institute of Liberal Arts and Sciences, Toyohashi University of Technology, Toyohashi, Japan","institution_ids":["https://openalex.org/I136259955"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5103172463"],"corresponding_institution_ids":["https://openalex.org/I136259955"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.40473888,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"1"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11976","display_name":"Capital Investment and Risk Analysis","score":0.9775999784469604,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11976","display_name":"Capital Investment and Risk Analysis","score":0.9775999784469604,"subfield":{"id":"https://openalex.org/subfields/2003","display_name":"Finance"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12722","display_name":"Innovation Policy and R&D","score":0.9578999876976013,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11903","display_name":"Private Equity and Venture Capital","score":0.9186999797821045,"subfield":{"id":"https://openalex.org/subfields/1402","display_name":"Accounting"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biopharmaceutical","display_name":"Biopharmaceutical","score":0.5410186052322388},{"id":"https://openalex.org/keywords/bankruptcy","display_name":"Bankruptcy","score":0.5257965922355652},{"id":"https://openalex.org/keywords/investment","display_name":"Investment (military)","score":0.5016851425170898},{"id":"https://openalex.org/keywords/business","display_name":"Business","score":0.48173144459724426},{"id":"https://openalex.org/keywords/equity","display_name":"Equity (law)","score":0.4796583950519562},{"id":"https://openalex.org/keywords/portfolio","display_name":"Portfolio","score":0.4469335973262787},{"id":"https://openalex.org/keywords/biotechnology","display_name":"Biotechnology","score":0.3708929419517517},{"id":"https://openalex.org/keywords/economics","display_name":"Economics","score":0.33623549342155457},{"id":"https://openalex.org/keywords/industrial-organization","display_name":"Industrial organization","score":0.323000431060791},{"id":"https://openalex.org/keywords/finance","display_name":"Finance","score":0.30832916498184204}],"concepts":[{"id":"https://openalex.org/C2781047461","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutical","level":2,"score":0.5410186052322388},{"id":"https://openalex.org/C504631918","wikidata":"https://www.wikidata.org/wiki/Q152074","display_name":"Bankruptcy","level":2,"score":0.5257965922355652},{"id":"https://openalex.org/C27548731","wikidata":"https://www.wikidata.org/wiki/Q88272","display_name":"Investment (military)","level":3,"score":0.5016851425170898},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.48173144459724426},{"id":"https://openalex.org/C199728807","wikidata":"https://www.wikidata.org/wiki/Q2578557","display_name":"Equity (law)","level":2,"score":0.4796583950519562},{"id":"https://openalex.org/C2780821815","wikidata":"https://www.wikidata.org/wiki/Q5340806","display_name":"Portfolio","level":2,"score":0.4469335973262787},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.3708929419517517},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.33623549342155457},{"id":"https://openalex.org/C40700","wikidata":"https://www.wikidata.org/wiki/Q1411783","display_name":"Industrial organization","level":1,"score":0.323000431060791},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.30832916498184204},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C94625758","wikidata":"https://www.wikidata.org/wiki/Q7163","display_name":"Politics","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1109/ice/itmc39735.2016.9026137","is_oa":false,"landing_page_url":"https://doi.org/10.1109/ice/itmc39735.2016.9026137","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2016 International Conference on Engineering, Technology and Innovation/IEEE lnternational Technology Management Conference (ICE/ITMC)","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.5699999928474426,"id":"https://metadata.un.org/sdg/9","display_name":"Industry, innovation and infrastructure"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2016389161","https://openalex.org/W3122549952","https://openalex.org/W4247025800","https://openalex.org/W2179014274","https://openalex.org/W2597027489","https://openalex.org/W577805051","https://openalex.org/W326514058","https://openalex.org/W2381785583","https://openalex.org/W2356340798","https://openalex.org/W1594002696"],"abstract_inverted_index":{"With":[0],"many":[1],"need-pull":[2],"innovations,":[3],"a":[4,15,48,52,68,104],"type":[5],"of":[6,71,79,83,88,139,141,154,169,193],"rare":[7],"basic-research-push":[8],"innovations":[9],"is":[10,23,43,65,149],"biopharmaceutical":[11],"development.":[12],"In":[13],"reflecting":[14],"next":[16],"generation":[17],"innovation,":[18],"NASDAQ":[19],"Biotechnology":[20],"Index":[21],"(NBI)":[22],"actually":[24],"moving":[25],"stronger":[26],"in":[27,46,108,125,197],"comparison":[28],"to":[29,110,166,179],"other":[30],"indicators.":[31],"From":[32],"the":[33,56,76,100,111,126,130,142,152,162,167,170,180,184,198],"industry,\u2019s":[34],"high":[35,112],"dependence":[36],"on":[37],"basic":[38],"research,":[39],"biotech":[40,96,117],"start-up,":[41],"which":[42],"more":[44],"excellent":[45],"combing":[47],"breakthrough":[49],"technology":[50],"and":[51,59,90,132,176,190],"niche":[53],"market":[54,58],"than":[55],"mass":[57],"low":[60,86],"risk-oriented":[61],"large":[62],"pharmaceutical":[63,80],"companies":[64,196],"expected":[66],"as":[67,103,151,173],"major":[69],"driver":[70],"innovation":[72],"chain.":[73],"However,":[74],"from":[75,121],"prolonging":[77],"period":[78],"development,":[81],"expansion":[82],"necessary":[84],"investment,":[85],"possibility":[87],"success,":[89],"severe":[91],"resource":[92],"constraints,":[93],"drug":[94],"discovery-based":[95],"start-up":[97,118,148],"must":[98],"endure":[99],"\u2018Death":[101],"Valley\u2019":[102],"long-term":[105,122],"deficit":[106,123],"state":[107],"addition":[109],"bankruptcy":[113],"rate.":[114],"Why":[115],"can":[116,144],"that":[119],"suffers":[120],"even":[124],"financial":[127],"crisis":[128],"continue":[129],"research":[131],"development":[133],"investment?":[134],"If":[135],"so,":[136],"what":[137],"kind":[138],"criteria":[140],"investment":[143],"be":[145],"utilized?":[146],"Biotech":[147],"defined":[150],"portfolio":[153],"real":[155,163],"options.":[156],"As":[157],"methodologies,":[158],"this":[159],"paper":[160],"applies":[161],"options":[164],"concept":[165],"assessment":[168],"stockholders\u2019":[171],"equity":[172,188],"technological":[174],"potential":[175],"Bayesian":[177],"MCMC":[178],"parameter":[181],"estimation":[182],"between":[183],"net":[185],"income,":[186],"shareholders\u2019":[187],"value,":[189],"R&D":[191],"costs":[192],"representative":[194],"30":[195],"NBI.":[199]},"counts_by_year":[],"updated_date":"2025-11-06T03:46:38.306776","created_date":"2025-10-10T00:00:00"}